The Probability of Locoregional Control in Patients With Locoregional Recurrent Breast Cancer Treated With Postoperative Reirradiation and Hyperthermia (RADHY): A Continuous Thermal Dose-effect Relationship.

IF 6.4 1区 医学 Q1 ONCOLOGY
C Paola Tello Valverde, Akke Bakker, H Petra Kok, M Willemijn Kolff, Geertjan van Tienhoven, Polychronis Kostoulas, Ben J Slotman, Konstantinos Pateras, Hans Crezee
{"title":"The Probability of Locoregional Control in Patients With Locoregional Recurrent Breast Cancer Treated With Postoperative Reirradiation and Hyperthermia (RADHY): A Continuous Thermal Dose-effect Relationship.","authors":"C Paola Tello Valverde, Akke Bakker, H Petra Kok, M Willemijn Kolff, Geertjan van Tienhoven, Polychronis Kostoulas, Ben J Slotman, Konstantinos Pateras, Hans Crezee","doi":"10.1016/j.ijrobp.2025.02.040","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Mild hyperthermia (HT) (39-43 °C) combined with reirradiation is considered for patients with locoregional recurrent (LRR) breast cancer. Studies analyzing dichotomized HT thermal dose (TD) parameters suggest that higher TD correlates with better response rates, but evidence quantifying optimal TD levels needed to achieve locoregional control (LRC) is limited. We investigated the continuous TD-effect relationship of LRC in patients with LRR breast cancer treated with postoperative reirradiation and HT.</p><p><strong>Methods and materials: </strong>In this historical cohort study, 112 patients with LRR breast cancer were treated in 2010-2017 with postoperative reirradiation 8 × 4 Gy (n = 34) or 23 × 2 Gy (n = 78) and 4 to 5 weekly HT sessions, TD was measured using invasive thermometry in the target region. Primary endpoint was the estimated probability of LRC at 5-years. The logarithm of highest (\"Best\") CEM43T50 (median cumulative equivalent minutes at 43 °C) of all HT sessions was analyzed as TD parameter based on Weibull univariate and stepwise multivariate regression analyses. Additionally, the best fitted Bayesian LRC survival model was analyzed assuming 3 informative priors: age, tumor location (breast/chest wall), and lymph node involvement.</p><p><strong>Results: </strong>Twenty-four patients developed an infield recurrence; median time to recurrence was 3.4 years (interquartile range, 2.7-4.6 years). Increasing median Best session CEM43T50 TD range from 0.08 to 101.9 minutes was associated with increasing probability of LRC from ∼44% to 94% at 5-years, and over this range a 2-fold TD increase resulted in ∼5% to 10% increasing LRC. The hazard ratio for a subsequent recurrence decreased 48% (95% confidence interval, 18%-84%) with a 2-fold increase in TD over the TD range, P = .001. This effect was confirmed in Weibull multivariate regression analysis and in Bayesian LRC survival regression analysis.</p><p><strong>Conclusions: </strong>Increasing TD was strongly associated with an improved LRC, showing that adequate TD must be ensured and confirming that HT is essential for strongly sensitizing efficacy of postoperative reirradiation for patients with LRR breast cancer.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2025.02.040","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Mild hyperthermia (HT) (39-43 °C) combined with reirradiation is considered for patients with locoregional recurrent (LRR) breast cancer. Studies analyzing dichotomized HT thermal dose (TD) parameters suggest that higher TD correlates with better response rates, but evidence quantifying optimal TD levels needed to achieve locoregional control (LRC) is limited. We investigated the continuous TD-effect relationship of LRC in patients with LRR breast cancer treated with postoperative reirradiation and HT.

Methods and materials: In this historical cohort study, 112 patients with LRR breast cancer were treated in 2010-2017 with postoperative reirradiation 8 × 4 Gy (n = 34) or 23 × 2 Gy (n = 78) and 4 to 5 weekly HT sessions, TD was measured using invasive thermometry in the target region. Primary endpoint was the estimated probability of LRC at 5-years. The logarithm of highest ("Best") CEM43T50 (median cumulative equivalent minutes at 43 °C) of all HT sessions was analyzed as TD parameter based on Weibull univariate and stepwise multivariate regression analyses. Additionally, the best fitted Bayesian LRC survival model was analyzed assuming 3 informative priors: age, tumor location (breast/chest wall), and lymph node involvement.

Results: Twenty-four patients developed an infield recurrence; median time to recurrence was 3.4 years (interquartile range, 2.7-4.6 years). Increasing median Best session CEM43T50 TD range from 0.08 to 101.9 minutes was associated with increasing probability of LRC from ∼44% to 94% at 5-years, and over this range a 2-fold TD increase resulted in ∼5% to 10% increasing LRC. The hazard ratio for a subsequent recurrence decreased 48% (95% confidence interval, 18%-84%) with a 2-fold increase in TD over the TD range, P = .001. This effect was confirmed in Weibull multivariate regression analysis and in Bayesian LRC survival regression analysis.

Conclusions: Increasing TD was strongly associated with an improved LRC, showing that adequate TD must be ensured and confirming that HT is essential for strongly sensitizing efficacy of postoperative reirradiation for patients with LRR breast cancer.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信